Impact of Abiraterone Acetate plus Prednisone or Enzalutamide on Patient-reported Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer: Final 12-mo Analysis from the Observational AQUARiUS Study

Antoine Thiery-Vuillemin*, Mads Hvid Poulsen, Edouard Lagneau, Guillaume Ploussard, Alison Birtle, Louis Marie Dourthe, Dominique Beal-Ardisson, Elias Pintus, Redas Trepiakas, Florence Lefresne, Martin Lukac, Suzy Van Sanden, Genevieve Pissart, Alison Reid

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

199 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Impact of Abiraterone Acetate plus Prednisone or Enzalutamide on Patient-reported Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer: Final 12-mo Analysis from the Observational AQUARiUS Study'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience